5HT 1 receptor agonists and metoclopramide for the treatment of migraine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 3, 2001
Grant Date -
N/A
app pub date -
Sep 1, 1999
filing date -
Oct 30, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a method of treating migraine in a mammal, including a human, by administering to the mammal a 5HT.sub.1 receptor agonist, and particularly eletriptan, in combination with metoclopramide. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT.sub.1 receptor agonist and metoclopramide.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully